» Articles » PMID: 24554449

Transcriptional and Posttranscriptional Regulation and Endocytosis Were Involved in Zinc Oxide Nanoparticle-induced Interleukin-8 Overexpression in Human Bronchial Epithelial Cells

Overview
Publisher Springer
Specialties Cell Biology
Toxicology
Date 2014 Feb 21
PMID 24554449
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Inhaled zinc oxide nanoparticles (ZnO-NPs) can induce lung inflammation through released inflammatory mediators, such as interleukin 8 (IL-8), from airways. However, the mechanisms underlying ZnO-NP-induced IL-8 gene expression have not been fully characterized. The transcription inhibitor actinomycin D (Act D) and the BEAS-2B cells stably overexpressing wild-type or mutated IL-8 promoter at the NFκB or C/EBPβ binding site were used to determine the involvement of transcriptional mechanisms. The effect of ZnO-NPs on IL-8 mRNA stability was examined using mRNA decay assay. The phagocytosis inhibitor cytochalasin B (CB) was utilized to define the role of endocytosis in ZnO-NP-induced IL-8 expression. In addition, the solubility of ZnO-NPs in culture medium was assessed using atomic absorption spectroscopy. Exposure to ZnO-NPs significantly increased the expression of IL-8 mRNA and protein in a dose-dependent manner. Pretreatment with Act D blocked ZnO-NP-induced IL-8 expression. Both NFκB and C/EBPβ transcription factors were required for ZnO-NP-induced IL-8 transcription. mRNA decay assay showed that ZnO-NP stimulation delayed IL-8 mRNA degradation in BEAS-2B cells. Pretreatment of BEAS-2B cells with CB blocked ZnO-NP-induced IL-8 expression by 30 %. Exposure to ZnO-NPs induced IL-8 gene expression through transcriptional activation and mRNA stabilization. Internalization of nanoparticles was partially involved in ZnO-NP-induced IL-8 expression.

Citing Articles

Identification of Exosomal miRNAs in Rats With Pulmonary Neutrophilic Inflammation Induced by Zinc Oxide Nanoparticles.

Qiao Y, Liang X, Yan Y, Lu Y, Zhang D, Yao W Front Physiol. 2018; 9:217.

PMID: 29593572 PMC: 5859358. DOI: 10.3389/fphys.2018.00217.


Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo.

Yan Z, Wang W, Wu Y, Wang W, Li B, Liang N Int J Nanomedicine. 2017; 12:4433-4442.

PMID: 28652743 PMC: 5476650. DOI: 10.2147/IJN.S134897.


Assessment of a panel of interleukin-8 reporter lung epithelial cell lines to monitor the pro-inflammatory response following zinc oxide nanoparticle exposure under different cell culture conditions.

Stoehr L, Endes C, Radauer-Preiml I, Boyles M, Casals E, Balog S Part Fibre Toxicol. 2015; 12:29.

PMID: 26415698 PMC: 4587722. DOI: 10.1186/s12989-015-0104-6.


Engineered metal based nanoparticles and innate immunity.

Petrarca C, Clemente E, Amato V, Pedata P, Sabbioni E, Bernardini G Clin Mol Allergy. 2015; 13(1):13.

PMID: 26180517 PMC: 4503298. DOI: 10.1186/s12948-015-0020-1.


Investigating the immunomodulatory nature of zinc oxide nanoparticles at sub-cytotoxic levels in vitro and after intranasal instillation in vivo.

Saptarshi S, Feltis B, Wright P, Lopata A J Nanobiotechnology. 2015; 13:6.

PMID: 25645871 PMC: 4324663. DOI: 10.1186/s12951-015-0067-7.